SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109442
Filing Date
2008-05-09
Accepted
2008-05-09 13:57:39
Documents
8
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 411123
2 AMENDED AND RESTATED ADDENDUM TO EMPLOYMENT AGREEMENT dex1059.htm EX-10.59 37121
3 BONUSES FOR NAMED EXECUTIVE OFFICERS APPROVED ON JANUARY 25, 2008 dex1060.htm EX-10.60 2196
4 SEPARATION AGREEMENT BETWEEN NUVELO, INC. AND MICHAEL D. LEVY dex1061.htm EX-10.61 21297
5 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex311.htm EX-31.1 5670
6 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR 15D-14(A) dex312.htm EX-31.2 5701
7 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SEC. 1350 dex321.htm EX-32.1 4738
8 GRAPHIC g56756image_1.jpg GRAPHIC 8809
  Complete submission text file 0001193125-08-109442.txt   501663
Mailing Address 201 INDUSTRIAL ROAD SUITE 310 SAN CARLOS CA 94070-6211
Business Address 201 INDUSTRIAL ROAD SUITE 310 SAN CARLOS CA 94070-6211 650-517-8000
NUVELO INC (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 08817539
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences